A Novel Class of

Living Medicines

Synthetic BioticTM medicines to perform and deliver critical therapeutic functions to treat diseases throughout the body

Latest News: Synlogic completes merger with Mirna Therapeutics and commences trading on NASDAQ under ticker symbol “SYBX”. The combined company has approximately $100 million in cash and cash equivalents following the transaction’s close. LEARN MORE >